Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
DSIP molecular weight: 848.85 g/mol
GLP-1s are a critical area of concern for employers and other plan sponsors as a cost driver in the pharmacy benefit
A growing therapeutic field The global market for obesity drugs is expected to hit $150 billion by 2035, $45 billion higher than a previous forecast owing to surging demands, according to a Morgan Stanley report
For instance, Eli Lillys once-weekly injectable GLP-1 receptor agonist, Trulicity (dulaglutide), is used along with diet and exercise to manage type 2 diabetes and reduce cardiovascular risk
The primary concern when using naproxen and Wegovy together relates to gastrointestinal tolerability rather than a direct drug-drug interaction
Oral Wegovy is available at 70,000+ U.S
